NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Neuphoria Therapeutics Inc. Common Stock Share Price Chart

NO DATA FOUND

Neuphoria Therapeutics Inc. Common Stock Performance Overview

Days Range
NALow
NAHigh

Markets Today

Previous CloseNA
OpenNA
VolumeNA
Day's RangeNA
52W RangeNA
Market Cap$20.08 M

Historical Performance

1M ReturnsNA
3M ReturnsNA
6M ReturnsNA
1Y ReturnsNA
5Y ReturnsNA
10Y ReturnsNA

Neuphoria Therapeutics Inc. Common Stock Fundamentals

Market Cap$20.08 M
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
RevenueN/A
ROE TTMN/A
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDAN/A
Profit MarginN/A
Market Cap$20.08 M
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
RevenueN/A
ROE TTMN/A
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDAN/A
Profit MarginN/A

Neuphoria Therapeutics Inc. Common Stock Return Calculator

The Neuphoria Therapeutics Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
Invest in USA Stock Today

About Neuphoria Therapeutics Inc. Common Stock

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.

FAQs

Neuphoria Therapeutics Inc. Common Stock (NEUP) share price as of September 19, 2026 is $undefined. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Neuphoria Therapeutics Inc. Common Stock (NEUP) Share by opening an international trading account with Angel One.
Purchasing Neuphoria Therapeutics Inc. Common Stock (NEUP) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Neuphoria Therapeutics Inc. Common Stock (NEUP) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Neuphoria Therapeutics Inc. Common Stock (NEUP) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Neuphoria Therapeutics Inc. Common Stock on September 19, 2026, is $20.08 M.
Neuphoria Therapeutics Inc. Common Stock operates in the null sector, specifically in the null industry.
In order to invest in Neuphoria Therapeutics Inc. Common Stock (NEUP) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91